For example, ANKRD1 is highly expressed in ovarian cancer and will increase the sensitivity of ovarian cancer cells to cisplatin after knockdown to enhance the therapeutic effect [33]. This evidence concerns the gene ANKRD1 and ovarian carcinoma.